Oncology and Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Moscow, Russia.
Center for Theoretical Problems of Physicochemical Pharmacology, Moscow, Russia.
Platelets. 2021 Oct 3;32(7):928-935. doi: 10.1080/09537104.2020.1817359. Epub 2020 Sep 16.
Megakaryocytes (MKs) are relatively rare in bone marrow, comprising <0.05% of the nucleated cells, which makes direct isolation from human bone marrow impractical. As such, in vitro expansion of primary MKs from patient samples offers exciting fundamental and clinical opportunities. As most of the developed ex vivo methods require a substantial volume of biomaterial, they are not widely performed on young patients. Here we propose a simple, robust, and adapted method of primary human MK culture from 1 mL of bone marrow aspirate. Our technique uses a small volume of bone marrow per culture, uses straightforward isolation methods, and generates approximately 6 × 10 mature MKs per culture. The relative high cell purity and yield achieved by this technique, combined with efficient use of low volumes of bone marrow, make this approach suitable for diagnostic and basic research of human megakaryopoiesis.
巨核细胞(MKs)在骨髓中相对较少,占有核细胞的<0.05%,这使得直接从人骨髓中分离不切实际。因此,从患者样本中体外扩增原代 MKs 提供了令人兴奋的基础和临床机会。由于大多数已开发的体外方法需要大量的生物材料,因此它们不能广泛用于年轻患者。在这里,我们提出了一种从 1 毫升骨髓抽吸物中培养原代人类 MK 的简单、稳健且适应性强的方法。我们的技术每培养物使用少量骨髓,使用简单的分离方法,每个培养物可产生约 6×10 个成熟的 MK。通过该技术获得的相对高的细胞纯度和产量,结合对低体积骨髓的有效利用,使该方法适用于人类巨核细胞生成的诊断和基础研究。